The facility generates power by utilizing 32 Francis turbines each of a capacity of 700 MW and two 50 MW turbines, totalling the installed capacity to 22,500 MW, more than twice the installed capacity of the largest nuclear power station, the Kashiwazaki-Kariwa (Japan) at 7,965 MW.
USE AND DOSE. VESIcare is for overactive bladder with symptoms of urgency, frequency, and leakage. The recommended dose of VESIcare is 5 mg once daily. If the 5 mg dose is well tolerated, your doctor may increase the dose to 10 mg once daily. VESIcare is not for everyone. If you have certain stomach or glaucoma problems, or trouble emptying your bladder, do not take VESIcare.
Potent topical steroids are becoming increasingly useful to treat these chronic conditions with good control. The purpose of this double-blind clinical trial was to compare clobetasol propionate and fluocinonide ointment in orabase as treatments for controlling oral vesiculoerosive diseases.Sixty patients were asked to participate (43 women and 17 men).verall, both medications had a beneficial effect in the control of symptoms and signs of oral vesiculoerosive diseases with minimal side effects. Clobetasol propionate was better than fluocinonide as measured by more rapid control of pain (within 7 days).